| 000 | 01538 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514162436.0 | ||
| 264 | 0 | _c20040628 | |
| 008 | 200406s 0 0 eng d | ||
| 022 | _a0033-3158 | ||
| 024 | 7 |
_a10.1007/s00213-003-1644-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLomeña, Francisco | |
| 245 | 0 | 0 |
_aStriatal dopamine D2 receptor density in neuroleptic-naive and in neuroleptic-free schizophrenic patients: an 123I-IBZM-SPECT study. _h[electronic resource] |
| 260 |
_bPsychopharmacology _cMar 2004 |
||
| 300 |
_a165-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xmetabolism |
| 650 | 0 | 4 |
_aBenzamides _xmetabolism |
| 650 | 0 | 4 |
_aCorpus Striatum _xdiagnostic imaging |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aProtein Binding _xphysiology |
| 650 | 0 | 4 |
_aPyrrolidines _xmetabolism |
| 650 | 0 | 4 |
_aReceptors, Dopamine D2 _xmetabolism |
| 650 | 0 | 4 |
_aSchizophrenia _xdiagnostic imaging |
| 650 | 0 | 4 | _aStatistics, Nonparametric |
| 650 | 0 | 4 |
_aTomography, Emission-Computed, Single-Photon _xmethods |
| 700 | 1 | _aCatafau, Ana M | |
| 700 | 1 | _aParellada, Eduard | |
| 700 | 1 | _aBernardo, Miquel | |
| 700 | 1 | _aFont, Mireia | |
| 700 | 1 | _aGutiérrez, Fernando | |
| 700 | 1 | _aPavía, Javier | |
| 773 | 0 |
_tPsychopharmacology _gvol. 172 _gno. 2 _gp. 165-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00213-003-1644-2 _zAvailable from publisher's website |
| 999 |
_c14361055 _d14361055 |
||